Literature DB >> 21892201

Comparison between cerebral state index and bispectral index as measures of electroencephalographic effects of sevoflurane using combined sigmoidal E(max) model.

Dong Woo Han1, Olinto-Jose Linares-Perdomo, Jong Seok Lee, Jun Ho Kim, Steven E Kern.   

Abstract

AIM: The cerebral state index (CSI) was recently introduced as an electroencephalographic monitor for measuring the depth of anesthesia. We compared the performance of CSI to the bispectral index (BIS) as electroencephalographic measures of sevoflurane effect using two combined sigmoidal E(max) models.
METHODS: Twenty adult patients scheduled for laparotomy were studied. After induction of general anesthesia, sevoflurane concentrations were progressively increased and then decreased over 70 min. An analysis of the BIS and CSI with the sevoflurane effect-site concentration was conducted using two combined sigmoidal E(max) models.
RESULTS: The BIS and CSI decreased over the initial concentration range of sevoflurane and then reached a plateau in most patients. A further increase in sevoflurane concentration produced a secondary plateau in the pharmacodynamic response. The CSI was more strongly correlated with effect-site sevoflurane concentration (R(2)=0.95±0.04) than the BIS was (R(2)=0.87±0.07) (P<0.05). The individual E(max) and C(eff50) (effect-site concentration associated with 50% decrease from baseline to plateau) values for the upper and lower plateaus were significantly greater for BIS (12.7±7.3, 1.6±0.4, and 4.2±0.5, respectively) than for CSI (3.4±2.2, 1.2±0.4, and 3.8±0.5, respectively) (P<0.05). The remaining pharmacodynamic parameters for the BIS and CSI were similar.
CONCLUSION: The overall performance of the BIS and CSI during sevoflurane anesthesia was similar despite major differences in their algorithms. However, the CSI was more consistent and more sensitive to changes in sevoflurane concentration, whereas the measured BIS seemed to respond faster. The newly developed combined E(max) model adequately described the clinical data, including the pharmacodynamic plateau.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892201      PMCID: PMC4010085          DOI: 10.1038/aps.2011.99

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  19 in total

1.  Onset of propofol-induced burst suppression may be correctly detected as deepening of anaesthesia by approximate entropy but not by bispectral index.

Authors:  J Bruhn; T W Bouillon; S L Shafer
Journal:  Br J Anaesth       Date:  2001-09       Impact factor: 9.166

2.  Application of Bispectral Index and Narcotrend index to the measurement of the electroencephalographic effects of isoflurane with and without burst suppression.

Authors:  Sascha Kreuer; Jörgen Bruhn; Reinhard Larsen; Ulrich Grundmann; Steven L Shafer; Wolfram Wilhelm
Journal:  Anesthesiology       Date:  2004-10       Impact factor: 7.892

3.  Comparative evaluation of the cerebral state index and the bispectral index during target-controlled infusion of propofol.

Authors:  T Zhong; Q L Guo; Y D Pang; L F Peng; C L Li
Journal:  Br J Anaesth       Date:  2005-10-06       Impact factor: 9.166

4.  Cerebral state index during propofol anesthesia: a comparison with the bispectral index and the A-line ARX index.

Authors:  Erik W Jensen; Hector Litvan; Miren Revuelta; Bernardo E Rodriguez; Pere Caminal; Pablo Martinez; Hugo Vereecke; Michel M R F Struys
Journal:  Anesthesiology       Date:  2006-07       Impact factor: 7.892

5.  Cerebral state monitor, a new small handheld EEG monitor for determining depth of anaesthesia: a clinical comparison with the bispectral index during day-surgery.

Authors:  R E Anderson; J G Jakobsson
Journal:  Eur J Anaesthesiol       Date:  2006-03       Impact factor: 4.330

6.  The influence of age on propofol pharmacodynamics.

Authors:  T W Schnider; C F Minto; S L Shafer; P L Gambus; C Andresen; D B Goodale; E J Youngs
Journal:  Anesthesiology       Date:  1999-06       Impact factor: 7.892

7.  Spectral entropy and bispectral index as measures of the electroencephalographic effects of sevoflurane.

Authors:  Richard Klaus Ellerkmann; Vidal-Markus Liermann; Thorsten Michael Alves; Ingobert Wenningmann; Sascha Kreuer; Wolfram Wilhelm; Heiko Roepcke; Andreas Hoeft; Jörgen Bruhn
Journal:  Anesthesiology       Date:  2004-12       Impact factor: 7.892

8.  A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect.

Authors:  V Billard; P L Gambus; N Chamoun; D R Stanski; S L Shafer
Journal:  Clin Pharmacol Ther       Date:  1997-01       Impact factor: 6.875

9.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

10.  Comparison between bispectral index and patient state index as measures of the electroencephalographic effects of sevoflurane.

Authors:  Martin Soehle; Richard K Ellerkmann; Matthias Grube; Matthias Kuech; Stefan Wirz; Andreas Hoeft; Joergen Bruhn
Journal:  Anesthesiology       Date:  2008-11       Impact factor: 7.892

View more
  3 in total

1.  Comparison between cerebral state index and bispectral index during desflurane anesthesia.

Authors:  Sang-Hyeon Cho; Sung-Su Kim; Dong-Min Hyun; Hyeong-Suk Yoon; Jung-Woo Han; Jin Sun Kim
Journal:  Korean J Anesthesiol       Date:  2018-05-09

2.  Correlation of Sedline-generated variables and clinical signs with anaesthetic depth in experimental pigs receiving propofol.

Authors:  Alessandro Mirra; Claudia Spadavecchia; Olivier Levionnois
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

3.  To clarify features of photoplethysmography in monitoring balanced anesthesia, compared with Cerebral State Index.

Authors:  Lieliang Zhang; Lei Xu; Juan Zhu; Yujie Gao; Zhonghua Luo; Hongyu Wang; Zhongliang Zhu; Yi Yu; Hongwei Shi; Hongguang Bao
Journal:  Med Sci Monit       Date:  2014-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.